1. Home
  2. MBOT vs HCWB Comparison

MBOT vs HCWB Comparison

Compare MBOT & HCWB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Microbot Medical Inc.

MBOT

Microbot Medical Inc.

HOLD

Current Price

$2.03

Market Cap

114.9M

Sector

Health Care

ML Signal

HOLD

Logo HCW Biologics Inc.

HCWB

HCW Biologics Inc.

SELL

Current Price

$2.03

Market Cap

14.2M

Sector

Health Care

ML Signal

SELL

Company Overview

Basic Information
Metric
MBOT
HCWB
Founded
2010
2018
Country
United States
United States
Employees
N/A
35
Industry
Medical/Dental Instruments
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
114.9M
14.2M
IPO Year
2000
2021

Fundamental Metrics

Financial Performance
Metric
MBOT
HCWB
Price
$2.03
$2.03
Analyst Decision
Strong Buy
Strong Buy
Analyst Count
3
1
Target Price
$7.50
$35.00
AVG Volume (30 Days)
1.7M
25.8M
Earning Date
05-15-2026
05-15-2026
Dividend Yield
N/A
N/A
EPS Growth
60.27
N/A
EPS
N/A
0.37
Revenue
$116,887.00
$4,099,750.00
Revenue This Year
N/A
N/A
Revenue Next Year
$119.77
N/A
P/E Ratio
N/A
$5.78
Revenue Growth
N/A
N/A
52 Week Low
$1.60
$0.25
52 Week High
$4.62
$7.83

Technical Indicators

Market Signals
Indicator
MBOT
HCWB
Relative Strength Index (RSI) 51.81 62.71
Support Level $2.00 $1.68
Resistance Level $2.28 $3.89
Average True Range (ATR) 0.15 0.60
MACD 0.02 0.11
Stochastic Oscillator 63.56 47.15

Price Performance

Historical Comparison
MBOT
HCWB

About MBOT Microbot Medical Inc.

Microbot Medical Inc is a medical device company specializing in the research, design, and development of next-generation robotic endoluminal surgery devices targeting the minimally invasive surgery space. Using its LIBERTY technological platform, the company has developed the LIBERTY Endovascular Robotic Surgical System, a fully disposable robot for various endovascular interventional procedures. The company has a single operating and reportable segment, which is the development of robotic devices for endoluminal surgery.

About HCWB HCW Biologics Inc.

HCW Biologics Inc is a clinical-stage biopharmaceutical company developing transformative fusion immunotherapeutics to support or treat diseases promoted by chronic inflammation. It has created novel compounds that represent a new class of drugs that it believes has the potential to fundamentally change the treatment of autoimmune disorders and other proinflammatory diseases, cancer and senescence-associated dysplasia. The company has developed two proprietary drug discovery and development platforms which it uses to create novel fusion immunotherapeutics: The TOBI (Tissue factOr-Based fusIon) platform, and The T-cell Receptor Beta Chain constant region (TRBC) platform. It operates and manages its business as one reportable segment.

Share on Social Networks: